StockNews.com began coverage on shares of Pulmatrix (NASDAQ:PULM – Free Report) in a report published on Tuesday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Pulmatrix Stock Up 2.2 % Shares of PULM stock opened at $1.94 on Tuesday. Pulmatrix has a 12 month low of $1.64 and a 12 month […]
StockNews.com initiated coverage on shares of Pulmatrix (NASDAQ:PULM – Free Report) in a report issued on Monday. The brokerage issued a hold rating on the biotechnology company’s stock. Pulmatrix Trading Up 5.7 % PULM opened at $1.94 on Monday. Pulmatrix has a 12-month low of $1.64 and a 12-month high of $4.49. The firm has […]
StockNews.com initiated coverage on shares of Pulmatrix (NASDAQ:PULM – Free Report) in a research note released on Friday. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright reissued a buy rating and set a $10.00 price target on shares of Pulmatrix in a research report on Tuesday, August 15th. Get […]
StockNews.com started coverage on shares of Pulmatrix (NASDAQ:PULM – Free Report) in a research report released on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright restated a buy rating and issued a $10.00 target price on shares of Pulmatrix in a research note on Tuesday, August 15th. Get […]
/PRNewswire/ Pulmatrix, Inc. (Nasdaq: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary.